A transformative approach to disease detection
Imagine diagnosing a disease before symptoms begin. Or diagnosing cancer without a biopsy. The proteins in our blood could be the key to making these things possible.
Imagine diagnosing a disease before symptoms begin. Or diagnosing cancer without a biopsy. The proteins in our blood could be the key to making these things possible.
BARRON'S | Kristin Forbes, Jerome and Dorothy Lemelson Professor of Management and Global Economics at MIT Sloan, does the math on Jerome Powell's tenure.
Our collaboration with Senator John Hickenlooper’s office on the BIG WIRES Act exemplifies exactly what we’re here to do.
PROJECT SYNDICATE | MIT’s Simon Johnson sat down with fellow Nobel laureate economist Philippe Aghion to examine what ails Europe and how to revive its dynamism. Their conversation addresses the costs of excessive regulation, the role of creative destruction in fostering competition, and the case fo...
A Financial Public Private Partnership to Cure Rare Diseases
Jiyoung Lee believes financial markets and public policy could be designed to support more effective and equitable climate adaptation. As a CPC post-doctoral researcher, her goal is to find out how.
Hosted by MIT Sloan and run by the MIT Sloan Sustainability Initiative, the event was the largest (and first-ever carbon-neutral!) ClimateCAP MBA Summit, bringing together nearly 400 MBA students from more than 45 business schools. Over the weekend, what stood out most wasn’t any single idea or solu...
Hosted by MIT Sloan, the event was the largest (and first-ever carbon-neutral) ClimateCAP MBA Summit, bringing together nearly 400 MBA students from more than 45 business schools.
CPC post-doc Juan Senga, is all about energy research, especially research that leads to policy that makes energy more renewable and affordable.
After more than a decade in pharmaceutical business development, Bill Desmarais, EMBA '16, found himself caught between two identities—too scientific for the business side and too business-oriented for the scientists. Seeking the skills and credibility to bridge that gap, he enrolled in the MIT Exec...